Sandberg E C, Riffle N L, Higdon J V, Getman C E
Am J Obstet Gynecol. 1981 May 15;140(2):194-205. doi: 10.1016/0002-9378(81)90108-3.
The presence of anomalies in vagina, cervix, and uterine body of women exposed to diethylstilbestrol in utero has provoked interest and concern regarding the reproductive potential of these women. To expand and to evaluate better better the current knowledge in this matter, the outcomes of the pregnancies of exposed women registered in the Stilbestrol Clinic at the Stanford University Medical Center were examined. The results were combined with the published results of similar examinations of other institutions and a summation of all available data is presented. Although it is evident that the majority (79%) of exposed women who have become pregnant and not regularly sought abortion have obtained at least one living infant, the incidence of spontaneous abortion and preterm delivery has consistently been found to be greater in exposed women than in unexposed control women. One of every 30 pregnancies reported in exposed patients has been ectopically located. Additionally, there is suggestive evidence that exposed women with teratologic changes have a higher incidence of pregnancy loss than those without such changes. However, few of these observations can boast statistical validity and statistical validation of the same observation by separate investigators has not been obtained. Moreover, none of th teratologic changes in exposed patients has been seen to preclude normal pregnancy and term delivery.
子宫内接触己烯雌酚的女性,其阴道、宫颈和子宫体出现异常,引发了人们对这些女性生殖潜能的关注。为了进一步拓展并更好地评估这方面的现有知识,我们对斯坦福大学医学中心己烯雌酚诊所登记的接触药物女性的妊娠结局进行了检查。研究结果与其他机构发表的类似检查结果相结合,并呈现了所有可用数据的汇总情况。虽然显然大多数(79%)怀孕且未定期寻求堕胎的接触药物女性至少生育了一名存活婴儿,但接触药物女性的自然流产和早产发生率一直高于未接触药物的对照女性。接触药物患者报告的每30次妊娠中就有1次为异位妊娠。此外,有提示性证据表明,有畸形变化的接触药物女性的妊娠丢失率高于无此类变化的女性。然而,这些观察结果中很少有具备统计学有效性的,且尚未获得不同研究者对同一观察结果的统计学验证。此外,未发现接触药物患者的任何畸形变化会妨碍正常妊娠和足月分娩。